KLF10 and metabolic dysfunction-associated steatotic liver disease: Taken together, the results suggest that KLF10 downregulated SREBP-1C through phosphorylation by AMPK, thereby regulating the complicated lipogenesis pathways to prevent the development of NAFLD.